<p>For these 24 MDR-TB patients out of 37 with multiple isolates, resistance to additional drugs was observed during treatment. Legend: ▪ = Susceptible, ▪ = Resistant, −Test not performed, I: Isoniazid, R: Rifampicin, E: Ethambutol, Z: Pyrazinamid, Rb: Rifabutin, Ofl: Ofloxacin, Amk: Amikacin, Thio: Thioamide, Cap: Capreomycin NA = Not Applicable as less than 2 isolates were FLP profiled, so no conclusion possible.</p
Objective: To determine the current sensitivity pattern of second line anti-tuberculosis drugs again...
<p>Legend: Mono resistant: resistance to a single drug out of the four tested; Poly resistant: resis...
1<p>Newly diagnosed cases.</p>2<p>Patient received >1 month of anti TB drug therapy.</p>3<p>Multidru...
Item does not contain fulltextOBJECTIVES: Treatment outcome of MDR-TB is critically dependent on the...
Molecular probe-based assays for common resistance muta-tions to isoniazid and rifampin (multidrug-r...
<div><p>With increasing incidence of multidrug-resistant tuberculosis (MDR-TB), accurate drug suscep...
OBJECTIVES: Treatment outcome of MDR-TB is critically dependent on the proper use of second-line dru...
With increasing incidence of multidrug-resistant tuberculosis (MDR-TB), accurate drug susceptibility...
Background: The emergence of multidrug resistance and extensively drug-resistant tuberculosis is a s...
R-res; Rifampicin Resistance. TAF-I; Treatment after Failure Category I. TAF-II; Treatment after Fai...
YesWe investigated whether companion drug resistance was associated with adverse outcome of the shor...
<p>MDR-TB is tuberculosis resistant to at least isoniazid and rifampin; XDR-TB is tuberculosis resis...
<p>Resistance profile (first and second-line) for all MDR-TB cases (abbreviations: H = isoniazid, R...
Objective: To determine the current sensitivity pattern of second line anti-tuberculosis drugs again...
Objective: To determine the current sensitivity pattern of second line anti-tuberculosis drugs again...
Objective: To determine the current sensitivity pattern of second line anti-tuberculosis drugs again...
<p>Legend: Mono resistant: resistance to a single drug out of the four tested; Poly resistant: resis...
1<p>Newly diagnosed cases.</p>2<p>Patient received >1 month of anti TB drug therapy.</p>3<p>Multidru...
Item does not contain fulltextOBJECTIVES: Treatment outcome of MDR-TB is critically dependent on the...
Molecular probe-based assays for common resistance muta-tions to isoniazid and rifampin (multidrug-r...
<div><p>With increasing incidence of multidrug-resistant tuberculosis (MDR-TB), accurate drug suscep...
OBJECTIVES: Treatment outcome of MDR-TB is critically dependent on the proper use of second-line dru...
With increasing incidence of multidrug-resistant tuberculosis (MDR-TB), accurate drug susceptibility...
Background: The emergence of multidrug resistance and extensively drug-resistant tuberculosis is a s...
R-res; Rifampicin Resistance. TAF-I; Treatment after Failure Category I. TAF-II; Treatment after Fai...
YesWe investigated whether companion drug resistance was associated with adverse outcome of the shor...
<p>MDR-TB is tuberculosis resistant to at least isoniazid and rifampin; XDR-TB is tuberculosis resis...
<p>Resistance profile (first and second-line) for all MDR-TB cases (abbreviations: H = isoniazid, R...
Objective: To determine the current sensitivity pattern of second line anti-tuberculosis drugs again...
Objective: To determine the current sensitivity pattern of second line anti-tuberculosis drugs again...
Objective: To determine the current sensitivity pattern of second line anti-tuberculosis drugs again...
<p>Legend: Mono resistant: resistance to a single drug out of the four tested; Poly resistant: resis...
1<p>Newly diagnosed cases.</p>2<p>Patient received >1 month of anti TB drug therapy.</p>3<p>Multidru...